Medical oncologist Dr. R. Julie Brahmer discusses biomarker testing and advanced treatment for lung cancer patients.

A new study suggests that a blood-based protein signature may help identify people at risk of lung cancer more accurately ...

A model based on proteins vs. a questionnaire had higher discrimination in predicting lung cancer risk in individuals with a smoking history, according to data presented at the American Thoracic ...

Breast cancer is a biologically heterogeneous disease in which genomic complexity, dynamic tumor evolution, and variable therapeutic response continue to ...